Chimeric Antigen Receptor T Cell Therapy Redirected to CD4 (CD4CAR)as a Second Line Treatment for Chronic Myelomonocytic Leukemia, CMML.

计划入组 30 人 · 首次发布于 2023 年 10 月 6 日

Tissue Study in Patients Undergoing CAR-T Cell Therapy (CAR_21_01)

计划入组 150 人 · 首次发布于 2021 年 5 月 19 日

Multi-4SCAR-T Therapy Targeting Breast Cancer

计划入组 100 人 · 首次发布于 2020 年 6 月 12 日

TCR T-cell therapy

anti-BCMA CAR T-cell therapy

PB-EPHB4-CAR T-cell therapy

Cell Therapy Ltd.

United Kingdom

Juventas Cell Therapy Ltd

China

Shanghai Cell Therapy Research Institute

China

CAR T-Cell Therapy Shows Promise in Treating Lupus

FDA Approves Ide-cel CAR T-Cell Therapy for Relapsed or Refractory Multiple Myeloma

CAR T-Cell Therapy Shows Promise Beyond Cancer in Treating Lupus